Tag
US FDA
- Larimar Therapeutics shares jump on positive FDA guidance
- Inovio advances DNA medicine for debilitating respiratory condition
- Whoop on the FDA hot seat for not following marketing rules
- Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test
- QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics
- Alibaba Group gets FDA nod for cancer detection tool
- Median Technologies clears hurdle on the way to regulatory acceptance in EU and US
- Scholar Rock stock skyrockets on successful phase 3 trial results
- Breath Diagnostics takes aim at lung cancer with One Breath
- FDA publishes first draft guidance document for psychedelics research
- FDA to reject medical device applications without cyberattack protection plans
- Natera and RenaCARE aim for early detection of kidney disease
- The Mugglehead technology roundup: glowing health edition
- Inadequate testing for CBD contaminants raises industry concerns: Leafreport
- Another bipartisan bill seeks to regulate CBD in US
- US Senate bill would finally allow CBD in food and drinks
- MindMed stock surges on Nasdaq listing approval
- Low‑THC weed led to poor results in major PTSD study
- Charlotte's Web bounces back in Q4
- Aloe vera extract producer funds McGill CBD pain research
- US FDA unveils plan to gather 'real-world' data to fill CBD research gaps
- Dousing strawberries in CBD oil reduces mould, extends shelf life: study
- Worm study shows CBD may extend life
- FDA's new draft guidelines could speed up CBD drug approvals
- Canopy launches Martha Stewart CBD line in cluttered US market
- Company study suggests inhalation of CBD safer than ingestion
- Revive Therapeutics approved by FDA for Phase 3 trial of possible Covid‑19 treatment
- Canopy launches CBD website in US despite lack of FDA regulations
- FDA issues cannabis research guidelines as CBD industry still hangs in limbo
- Aleafia Health clinics to offer ketamine-based antidepressant
- Canopy to launch Martha Stewart CBD brand this fall
- Charlotte's Web backs study on health outcomes of CBD
- Aurora continues winning streak on US CBD deal
- Tetra Bio‑Pharma gets 5th orphan drug status for CBD topical
- Florida's new medical cannabis limits could drive patients underground: lawyer